Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, and Regeneron Pharmaceuticals, Inc.
Disruptors are among the biggest winners, says Jim Cramer. Companies like Apple and Kraft Heinz need to re-imagine their companies in bold, meaningful and even radical ways.
In this day and age, companies must be 'disruptors' or get left in the dust.
Top Award of $250,000 Goes to Ana Humphrey of Virginia in Nation's Oldest and Most Prestigious STEM Competition for High School Seniors
Only therapy that targets the IL-4/IL-13 pathway, a key driver of the allergic or type 2 inflammation that underlies atopic dermatitis
* Only therapy that targets the IL-4/IL-13 pathway, a key driver of the allergic or type 2 inflammation that underlies atopic dermatitis
TARRYTOWN, N.Y.
Teva's CEO explains why 2019 is a trough year for the Israeli pharma company.
TARRYTOWN, N.Y.
* This is the latest step by the companies to help make Praluent more accessible and affordable for appropriate patients
Weekly Regeneron chart shows a strong breakout.
